SEVEN EIGHT CAPITAL, LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$80,792
-47.8%
10,398
-34.9%
0.01%
-65.4%
Q2 2023$154,715
+15.5%
15,983
-10.6%
0.03%
-3.7%
Q3 2022$134,000
-62.4%
17,881
-49.5%
0.03%
-81.1%
Q2 2022$356,000
-74.6%
35,408
-68.7%
0.14%
-23.5%
Q1 2022$1,403,000
-78.1%
113,303
-60.8%
0.19%
-69.6%
Q3 2021$6,392,000
+994.5%
288,840
+540.7%
0.62%
+651.2%
Q2 2021$584,000
+8.8%
45,080
+23.7%
0.08%
-29.3%
Q3 2020$537,000
+52.1%
36,434
+49.9%
0.12%
+27.5%
Q1 2020$353,00024,3000.09%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders